95 related articles for article (PubMed ID: 2655092)
1. Carboplatin (JM-8, CBDCA). A new platinum compound.
Semin Oncol; 1989 Apr; 16(2 Suppl 5):1-48. PubMed ID: 2655092
[No Abstract] [Full Text] [Related]
2. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).
Curt GA; Grygiel JJ; Corden BJ; Ozols RF; Weiss RB; Tell DT; Myers CE; Collins JM
Cancer Res; 1983 Sep; 43(9):4470-3. PubMed ID: 6347373
[TBL] [Abstract][Full Text] [Related]
3. Paraplatin (carboplatin): new advances in cancer therapy. Update on clinical experiences. Proceedings of a satellite symposium. Madrid, Spain, 2 November 1987.
Cancer Treat Rev; 1988 Jun; 15 Suppl B():1-44. PubMed ID: 3042129
[No Abstract] [Full Text] [Related]
4. Whither carboplatin? A replacement for or an alternative to cisplatin?
Gil A
J Clin Oncol; 1987 Dec; 5(12):2041-2. PubMed ID: 3316520
[No Abstract] [Full Text] [Related]
5. Paraplatin (carboplatin). Current status and future prospects. Proceedings of a satellite symposium held at Stockholm, Sweden, 19th June 1985, during the 3rd European Conference on Clinical Oncology.
Cancer Treat Rev; 1985 Sep; 12 Suppl A():1-152. PubMed ID: 3910214
[No Abstract] [Full Text] [Related]
6. [Antitumor effect of JM-8 (a cisplatin analogue) on testicular cancer cells in vitro and in vivo].
Hashimura T; Okada K; Yoshida O
Gan To Kagaku Ryoho; 1985 May; 12(5):1137-42. PubMed ID: 3888118
[TBL] [Abstract][Full Text] [Related]
7. [Carboplatin--a new platinum cytostatic].
Hejl J; Hejlová N; Mechl Z; Pípalová I; Jurásková V
Cas Lek Cesk; 1985 Jul; 124(29):917-8. PubMed ID: 3899362
[No Abstract] [Full Text] [Related]
8. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
Hecquet B; Caty A; Fournier C; Lefebvre JL; Adenis L
Bull Cancer; 1987; 74(4):433-6. PubMed ID: 3311237
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Taniguchi H; Tateishi R; Mori Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):693-8. PubMed ID: 3548596
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor activity of a new platinum complex (R)-(-)-2-aminomethylpyrrolidine (1,1-cyclobutane dicarboxylato) platinum (II) (DWA2114R) by its serial administration].
Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Mitsui H; Koizumi K; Matsuno T
Gan To Kagaku Ryoho; 1989 May; 16(5):2039-43. PubMed ID: 2658840
[TBL] [Abstract][Full Text] [Related]
11. [Results of a phase-I clinical study of carboplatin--(cyclobutane-1,1-dicarboxylate)diamineplatinum (II)].
Gorbunova VA
Vestn Akad Med Nauk SSSR; 1986; (5):45-7. PubMed ID: 3524054
[No Abstract] [Full Text] [Related]
12. CBDCA: phase II evaluation in advanced colorectal carcinoma.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Apr; 10(2):136-8. PubMed ID: 3551576
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of carboplatin (CBDCA) in children with cancer.
Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
Boven E; van der Vijgh WJ; Nauta MM; Schlüper HM; Pinedo HM
Cancer Res; 1985 Jan; 45(1):86-90. PubMed ID: 4038381
[TBL] [Abstract][Full Text] [Related]
15. Clinical status of carboplatin.
Canetta R; Franks C; Smaldone L; Bragman K; Rozencweig M
Oncology (Williston Park); 1987 Jul; 1(5):61-70. PubMed ID: 3079484
[TBL] [Abstract][Full Text] [Related]
16. Vestibular morphological analysis of the effects of cisplatin vs. platinum analogs, CBDCA (JM-8) and CHIP (JM-9).
Schweitzer VG; Rarey KE; Dolan DF; Abrams GE; Sheridan C
Laryngoscope; 1986 Sep; 96(9 Pt 1):959-74. PubMed ID: 3528727
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin.
Med Lett Drugs Ther; 1989 Sep; 31(800):83-4. PubMed ID: 2671623
[No Abstract] [Full Text] [Related]
18. [Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA) in humans].
Zucca E; Cattaneo MT; Cavalli F; Guaitani A; Filipazzi V; Bartosek I
G Ital Chemioter; 1985; 32(1):25-8. PubMed ID: 3913618
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.
Egorin MJ; Van Echo DA; Tipping SJ; Olman EA; Whitacre MY; Thompson BW; Aisner J
Cancer Res; 1984 Nov; 44(11):5432-8. PubMed ID: 6386150
[TBL] [Abstract][Full Text] [Related]
20. A case report of adenocarcinoma of the lung in which a partial response was achieved by carboplatin.
Akiba T; Saijo N; Miyamoto K; Taguchi J; Taito H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T
Jpn J Clin Oncol; 1987 Jun; 17(2):173-8. PubMed ID: 3302380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
